Track topics on Twitter Track topics that are important to you
Phone: 32 2 609 22 22
Fax: 32 2 731 70 49
The FDA has granted Medtronic 510(k) clearance to market its Kyphon HV-R bone cement for fixation of pathological fractures o -More-
Delivering Commitment to Find New Treatment Options for PatientsSuffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018- Medtronic plc (NYSE: MDT) today announced the U....
The objective of this study is to measure the effect that the scraping and scoring of vertebral cancellous bone using the Kyphon® Curette has on vertebral body anatomy height restoration ...
The purpose of this clinical study is to confirm the efficacy and safety of the Kyphon®Xpede™ Bone Cement in human use in China.
Since its founding in 1994, Kyphon has been dedicated to improving patient quality of life through revolutionizing the practice of medicine. Kyphon's mission is to be the recognized global leader in r...
We have published hundreds of Kyphon news stories on BioPortfolio along with dozens of Kyphon Clinical Trials and PubMed Articles about Kyphon for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kyphon Companies in our database. You can also find out about relevant Kyphon Drugs and Medications on this site too.